ArticleScientific reports2015

EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome.

Isaac Canals et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.